Energy metabolism in neuronal/glial induction and in iPSC models of brain disorders.

Barbara Mlody,C. Lorenz,Gizem Inak,A. Prigione

DOI: https://doi.org/10.1016/j.semcdb.2016.02.018

IF: 7.3

2016-04-01

Seminars in Cell and Developmental Biology

Abstract:

What problem does this paper attempt to address?

Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women

Seong-Hee Ko,Hyun-Sook Kim

DOI: https://doi.org/10.3390/nu12010202

IF: 5.9

2020-01-13

Nutrients

Abstract:Menopause is clinically diagnosed as a condition when a woman has not menstruated for one year. During the menopausal transition period, there is an emergence of various lipid metabolic disorders due to hormonal changes, such as decreased levels of estrogens and increased levels of circulating androgens; these may lead to the development of metabolic syndromes including cardiovascular diseases and type 2 diabetes. Dysregulation of lipid metabolism affects the body fat mass, fat-free mass, fatty acid metabolism, and various aspects of energy metabolism, such as basal metabolic ratio, adiposity, and obesity. Moreover, menopause is also associated with alterations in the levels of various lipids circulating in the blood, such as lipoproteins, apolipoproteins, low-density lipoproteins (LDLs), high-density lipoproteins (HDL) and triacylglycerol (TG). Alterations in lipid metabolism and excessive adipose tissue play a key role in the synthesis of excess fatty acids, adipocytokines, proinflammatory cytokines, and reactive oxygen species, which cause lipid peroxidation and result in the development of insulin resistance, abdominal adiposity, and dyslipidemia. This review discusses dietary recommendations and beneficial compounds, such as vitamin D, omega-3 fatty acids, antioxidants, phytochemicals—and their food sources—to aid the management of abnormal lipid metabolism in postmenopausal women.

nutrition & dietetics
Plant Heat Adaptation: priming in response to heat stress

I. Bäurle

DOI: https://doi.org/10.12688/f1000research.7526.1

2016-04-18

F1000Research

Abstract:Abiotic stress is a major threat to crop yield stability. Plants can be primed by heat stress, which enables them to subsequently survive temperatures that are lethal to a plant in the naïve state. This is a rapid response that has been known for many years and that is highly conserved across kingdoms. Interestingly, recent studies in Arabidopsis and rice show that this thermo-priming lasts for several days at normal growth temperatures and that it is an active process that is genetically separable from the priming itself. This is referred to as maintenance of acquired thermotolerance or heat stress memory. Such a memory conceivably has adaptive advantages under natural conditions, where heat stress often is chronic or recurring. In this review, I will focus on recent advances in the mechanistic understanding of heat stress memory.
Obesity and menopause

Santiago Palacios,Peter Chedraui,Rafael Sánchez-Borrego,Pluvio Coronado,Rossella E. Nappi

DOI: https://doi.org/10.1080/09513590.2024.2312885

2024-02-13

Gynecological Endocrinology

Abstract:Obesity is not a choice or a result of lack of willpower, but a multifactorial, chronic, progressive, and relapsing disease. During menopause, hormonal and body composition changes lead to greater visceral adiposity, that aggravates women's health at a cardiometabolic, mechanic and mental level. Adiposity has been identified as an important modifier of reproductive hormones. During female midlife, obesity has been associated with menstrual cycle alterations (anovulatory cycles ending with abnormal bleedings), menopausal symptoms including hot flashes, poor quality of sleep, aches and joint pain, genitourinary symptoms, and reduced quality of life. However, the relationships between weight, the menopausal process, aging, and hormone levels remain poorly understood. Women with obesity have an increased risk of thromboembolic disease when using menopause hormone therapy (MHT), and it is probably the main medical condition to prescribe or not MHT. However, this risk depends on the route and type of MHT. The use of estrogen-only or combined transdermal MHT does not increase the risk of a thrombotic event in women with obesity.

endocrinology & metabolism,obstetrics & gynecology
Cardiovascular Changes in Menopause

Anjana R Nair,Aiswarya J Pillai,Nandini Nair

DOI: https://doi.org/10.2174/1573403X16666201106141811

Abstract:Menopause is associated with changes consistent with cardiovascular aging. The effects of cardiac disease are multifaceted, affecting endothelial function, coronary artery physiology and metabolic dysfunction leading to structural changes in the coronary anatomy. A systematic review of literature from 1986 to 2019 was conducted using PubMed and Google Scholar. The search was directed to retrieve papers that addressed the changes in cardiovascular physiology in menopause and the current therapies available to treat cardiovascular manifestations of menopause. The metabolic and clinical factors secondary to menopause, such as dyslipidemia, insulin resistance, fat redistribution and systemic hypertension, contribute to the accelerated risk for cardiovascular aging and disease. Atherosclerosis appears to be the end result of the interaction between cardiovascular risk factors and their accentuation during the perimenopausal period. Additionally, complex interactions between oxidative stress and levels of L-arginine and ADMA may also influence endothelial dysfunction in menopause. The increased cardiovascular risk in menopause stems from the exaggerated effects of changing physiology on the cardiovascular system affecting peripheral, cardiac and cerebrovascular beds. The differential effects of menopause on cardiovascular disease at the subclinical, biochemical and molecular levels form the highlights of this review.
Optical system invariant to second-order aberrations.

A. Samokhin,A. Simonov,M. Rombach

DOI: https://doi.org/10.1364/JOSAA.26.000977

2009-04-01

Abstract:An approximate analytical expression is derived for the two-dimensional incoherent optical transfer function (OTF) of an imaging system invariant to second-order aberrations. The system broadband behavior resulting from a third-order phase mask in its pupil plane is analyzed by using the two-dimensional stationary phase method. This approach does not require mathematical separability of the pupil function and can be applied to any pupil shape. The OTF is found to be a well-defined and smooth function at all nonzero spatial frequencies when the phase mask function includes third-order mixed terms in the pupil coordinates.
Detrimental Changes in Health during Menopause: The Role of Physical Activity

Ryan M Hulteen,Kara L Marlatt,Timothy D Allerton,Dragana Lovre

DOI: https://doi.org/10.1055/a-2003-9406

Abstract:Midlife women experience changes in cardiometabolic, physical, and psychosocial health during menopause that negatively impacts their overall quality of life. Factors that contribute to these increases in cardiometabolic risk include weight gain as well as increases in fat mass (particularly abdominal adiposity), insulin resistance, and vascular dysfunction. Other deleterious changes in physical health (e. g. reduced sleep health, bone density, and balance) as well as changes in psychosocial health (e. g. mood, anxiety, and depression) often coincide and are linked to these increases in cardiometabolic risk. Physical activity and exercise are important lifestyle components that have been demonstrated to improve cardiometabolic, physical, and psychosocial health, yet physical activity and exercise is known to decline during perimenopause and into the postmenopausal years. In this narrative review, we summarize these changes in overall health during menopause as well as how declining physical activity contributes to these changes. Additionally, we discuss how incorporating physical activity and exercise during menopause can potentially ameliorate health declines. We conclude that there exists a significant, positive impact of physical activity on cardiometabolic, physical, and psychological health among midlife women, particularly if undertaken during the perimenopausal and postmenopausal years.
[Quaking mice: study of sleep and of epileptic seizures].

J. Valatx,M. Jouvet

1971-06-01

Abstract:
Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women

Seong-Hee Ko,YunJae Jung

DOI: https://doi.org/10.3390/nu13124556

IF: 5.9

2021-12-20

Nutrients

Abstract:Aging women experience hormonal changes, such as decreased estrogen and increased circulating androgen, due to natural or surgical menopause. These hormonal changes make postmenopausal women vulnerable to body composition changes, muscle loss, and abdominal obesity; with a sedentary lifestyle, these changes affect overall energy expenditure and basal metabolic rate. In addition, fat redistribution due to hormonal changes leads to changes in body shape. In particular, increased bone marrow-derived adipocytes due to estrogen loss contribute to increased visceral fat in postmenopausal women. Enhanced visceral fat lipolysis by adipose tissue lipoprotein lipase triggers the production of excessive free fatty acids, causing insulin resistance and metabolic diseases. Because genes involved in β-oxidation are downregulated by estradiol loss, excess free fatty acids produced by lipolysis of visceral fat cannot be used appropriately as an energy source through β-oxidation. Moreover, aged women show increased adipogenesis due to upregulated expression of genes related to fat accumulation. As a result, the catabolism of ATP production associated with β-oxidation decreases, and metabolism associated with lipid synthesis increases. This review describes the changes in energy metabolism and lipid metabolic abnormalities that are the background of weight gain in postmenopausal women.

nutrition & dietetics
Plasma Metabolic Profiles In Women Are Menopause Dependent

Chaofu Ke,Yan Hou,Haiyu Zhang,Kai Yang,Jingtao Wang,Bing Guo,Fan Zhang,Hailong Li,Xiaohua Zhou,Ying Li,Kang Li

DOI: https://doi.org/10.1371/journal.pone.0141743

IF: 3.7

2015-01-01

PLoS ONE

Abstract:Menopause is an endocrinological transition that greatly affects health and disease susceptibility in middle-aged and elderly women. To gain new insights into the metabolic process of menopause, plasma metabolic profiles in 115 pre-and post-menopausal women were systematically analyzed by ultra-performance liquid chromatography/mass spectrometry in conjunction with univariate and multivariate statistical analysis. Metabolic signatures revealed considerable differences between pre-and post-menopausal women, and clear separations were observed between the groups in partial least-squares discriminant analysis score plots. In total, 28 metabolites were identified as potential metabolite markers for menopause, including up-regulated acylcarnitines, fatty acids, lysophosphatidylcholines, lysophosphatidylethanolamines, and down-regulated pregnanediol-3-glucuronide, dehydroepiandrosterone sulfate, p-hydroxyphenylacetic acid and dihydrolipoic acid. These differences highlight that significant alterations occur in fatty acid beta-oxidation, phospholipid metabolism, hormone metabolism and amino acid metabolism in post-menopausal women. In conclusion, our plasma metabolomics study provides novel understanding of the metabolic profiles related to menopause, and will be useful for investigating menopause-related diseases and assessing metabolomic confounding factors.
The Importance of Nutrition in Menopause and Perimenopause-A Review

Aliz Erdélyi,Erzsébet Pálfi,László Tűű,Katalin Nas,Zsuzsanna Szűcs,Marianna Török,Attila Jakab,Szabolcs Várbíró

DOI: https://doi.org/10.3390/nu16010027

IF: 5.9

2023-12-21

Nutrients

Abstract:Menopause is associated with an increased prevalence of obesity, metabolic syndrome, cardiovascular diseases, and osteoporosis. These diseases and unfavorable laboratory values, which are characteristic of this period in women, can be significantly improved by eliminating and reducing dietary risk factors. Changing dietary habits during perimenopause is most effectively achieved through nutrition counseling and intervention. To reduce the risk factors of all these diseases, and in the case of an already existing disease, dietary therapy led by a dietitian should be an integral part of the treatment. The following review summarizes the recommendations for a balanced diet and fluid intake, the dietary prevention of cardiovascular diseases, the role of sleep, and the key preventive nutrients in menopause, such as vitamin D, calcium, vitamin C, B vitamins, and protein intake. In summary, during the period of perimenopause and menopause, many lifestyle factors can reduce the risk of developing all the diseases (cardiovascular disease, insulin resistance, type 2 diabetes mellitus, osteoporosis, and tumors) and symptoms characteristic of this period.
Effects of High Fat Diet on Metabolic Health Vary by Age of Menopause Onset

Abigail E. Salinero,Harini Venkataganesh,Charly Abi-Ghanem,David Riccio,Richard D. Kelly,Olivia J. Gannon,Avi Sura,Heddwen L. Brooks,Kristen L. Zuloaga

DOI: https://doi.org/10.1101/2024.01.18.576269

2024-01-20

Abstract:Menopause accelerates metabolic dysfunction, including (pre-)diabetes, obesity and visceral adiposity. However, the effects of endocrine vs. chronological aging in this progression are poorly understood. We hypothesize that menopause, especially in the context of middle-age, will exacerbate the metabolic effects of a high fat diet. Using young-adult and middle-aged C57BL/6J female mice, we modeled diet-induce obesity via chronic administration of high fat (HF) diet vs. control diet. We modeled peri-menopause/menopause via injections of 4-vinylcyclohexene diepoxide, which accelerates ovarian failure vs. vehicle. We performed glucose tolerance tests 2.5 and 7 months after diet onset, during the peri-menopausal and menopausal phases, respectively. Peri-menopause increased the severity of glucose intolerance and weight gain in middle-aged, HF-fed mice. Menopause increased weight gain in all mice regardless of age and diet, while chronological aging drove changes in adipose tissue distribution towards more visceral vs. subcutaneous adiposity. These data are in line with clinical data showing that post-menopausal women are more susceptible to metabolic dysfunction and suggest that greater chorological age exacerbates the effects of endocrine aging (menopause). This work highlights the importance of considering both chronological and endocrine aging in studies of metabolic health.

Neuroscience
Sacrococcygeal appendage with femur: exoparasitic pyropagus twin, mature teratoma, or disorganization-like syndrome?

Sebastien Mbuyi-Musanzayi,T. Kasole,Prosper Kalenga Muenze,P. Tshilobo,T. K. Kitenge,L. Ngombe,F. Katombe,K. Devriendt

DOI: https://doi.org/10.1097/MCD.0000000000000086

2015-10-01

Clinical Dysmorphology

Abstract:Departments of Surgery, Pediatrics, Gynecology, Public Health, Unit of Toxicology and Environment, School of Public Health, University Hospital, Center for Human Genetics, Faculty of Medicine, University of Lubumbashi, Lubumbashi, Department of Pediatrics, University Hospitals, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo and Center for Human Genetics, University Hospitals, KU Leuven, Leuven, Belgium Correspondence to Koenraad Devriendt, PhD, Centre of Human Genetics, UZ Leuven Campus Gasthuisberg, Herestraat 49, B – 3000 Leuven, Belgium Tel: + 32 16 34 59 03; fax: + 32 16 34 60 60; e-mail: koenraad.devriendt@uzleuven.be
Heart Failure in Menopause: Treatment and New Approaches

Jaqueline S da Silva,Tadeu Lima Montagnoli,Mauro Paes Leme de Sá,Gisele Zapata-Sudo

DOI: https://doi.org/10.3390/ijms232315140

2022-12-01

Abstract:Aging is an important risk factor for the development of heart failure (HF) and half of patients with HF have preserved ejection fraction (HFpEF) which is more common in elderly women. In general, sex differences that lead to discrepancies in risk factors and to the development of cardiovascular disease (CVD) have been attributed to the reduced level of circulating estrogen during menopause. Estrogen receptors adaptively modulate fibrotic, apoptotic, inflammatory processes and calcium homeostasis, factors that are directly involved in the HFpEF. Therefore, during menopause, estrogen depletion reduces the cardioprotection. Preclinical menopause models demonstrated that several signaling pathways and organ systems are closely involved in the development of HFpEF, including dysregulation of the renin-angiotensin system (RAS), chronic inflammatory process and alteration in the sympathetic nervous system. Thus, this review explores thealterations observed in the condition of HFpEF induced by menopause and the therapeutic targets with potential to interfere with the disease progress.
The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis

Jiajun Liu,Xueshan Jin,Wenbin Liu,Wanying Chen,Lan Wang,Ziyi Feng,Jieming Huang

DOI: https://doi.org/10.3389/fcvm.2023.1131251

IF: 3.6

2023-03-22

Frontiers in Cardiovascular Medicine

Abstract:Background: Transition into menopause is associated with an increased risk of cardiovascular disease (CVD). However, it is unclear whether the association exists between premature menopause (defined as age at menopause 40 years) or early menopause (defined as age at menopause 40–45 years) and CVD or cardiovascular risk factors. The aim of this review was to comprehensively evaluate and meta-analyze the most reliable evidence about the relationship between menopausal age and the risk of long-term cardiometabolic disease. Methods: A comprehensive literature search of the PubMed, Web of Science, and Embase databases from inception to October 1, 2022, for titles and abstracts with a restriction to English language papers led to the discovery of the studies. Data are expressed as the Hazard Ratio (HR) with 95% confidence intervals (CI). The degree of heterogeneity was measured using the I-square ( I 2 ) index. Results: 921,517 participants from 20 cohort studies published between 1998 and 2022 were considered. Compared to women with menopause at age >45 years, women with premature menopause (PM) or early menopause (EM) had a higher risks of type 2 diabetes (RR: 1.32, 95% CI: 1.08–1.62; RR: 1.11, 95% CI: 0.91–1.36, respectively), hyperlipidemia (RR: 1.21, 95% CI: 1.05–1.39; RR: 1.17, 95% CI: 1.02–1.33, respectively), coronary heart disease (RR: 1.52, 95% CI: 1.22–1.91; RR: 1.19, 95% CI: 1.07–1.32, respectively), stroke (RR: 1.27, 95% CI: 1.02–1.58; RR: 1.13, 95% CI: 0.97–1.32, respectively) and total cardiovascular event (RR: 1.36, 95% CI: 1.16–1.60; RR: 1.14, 95% CI: 0.97–1.35, respectively). No difference was found for hypertension in PM or EM women (RR: 0.98, 95% CI: 0.89–1.07; RR: 0.97, 95% CI: 0.91–1.04, respectively). Additionally, we also found that PM women, but not EM women, were linked with an increased risk of ischemic and hemorrhagic stroke. However, this is not in line with the conclusion that both PM and EM had a higher risk of total stroke. Conclusion: Women with PM or EM have a higher risk of developing long-term CVD, compared to women with menopause at age >45 years. Therefore, we recommend early lifestyle interventions (e.g., maintaining a healthy lifestyle) and medical treatments (e.g., timely initiation of menopausal hormone therapy) to decrease the risk of cardiometabolic disease in early or premature menopausal women. Systematic Review Registration: PROSPERO, identifier CRD42022378750

cardiac & cardiovascular systems
Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women

Gyu Chul Oh,Kee Soo Kang,Chan Soon Park,Ho Kyung Sung,Kyoung Hwa Ha,Hyeon Chang Kim,Sungha Park,Sang Hyun Ihm,Hae-Young Lee

DOI: https://doi.org/10.1186/s40885-018-0099-z

2018-10-15

Clinical Hypertension

Abstract:BackgroundIt has been long debated whether menopause itself is a risk factor for hypertension in peri-menopausal women. We aimed to assess the association between menopause and hypertension, and whether metabolic syndrome (MetS) has an influence on its effect.MethodsData for 1502 women aged 42 to 53 from the Korean Genome and Epidemiology Study (KoGES) database were retrospectively analyzed. The KoGES database consists of 10,038 participants, of which 52.6% (5275) were female. Subjects were followed up for 4 years, and compared according to menopausal status. Additionally, 1216 non-hypertensive subjects were separately analyzed to assess whether a change in menopausal status was associated with development of hypertension.ResultsThe prevalence of hypertension, diabetes, and MetS for menopausal and non-menopausal subjects at baseline was 24.4% vs. 16.7%, 5.8% vs. 2.9%, and 25.4% vs. 16.6%, respectively (p < 0.01 for all comparisons). Among non-hypertensive subjects at baseline, prevalence of hypertension at 4-year follow-up was 9.4%, 19.7%, and 13.1% for non-menopausal, those who became menopause during follow-up, and those who were menopause at baseline, respectively. Development of hypertension was positively correlated with MetS (HR 3.90, 95% CI 2.51–6.07) and increased BMI (HR 1.09, 95% CI 1.03–1.16), while association with menopause was not significant.ConclusionsMenopause is closely associated with increased incidence of hypertension, but the increase may not be attributable to menopause itself but to increased prevalence of MetS.
Endocrinology of Menopause

Beatrice J Edwards,Jin Li

DOI: https://doi.org/10.1111/j.1600-0757.2011.00407.x

2013-01-01

Periodontology 2000

Abstract:Menopause is a natural process that occurs in women’s lives as part of normal aging. Many women go through the menopausal transition with few or no symptoms, while some have significant, or even disabling, symptoms. This manuscript reviews the physiologic processes and symptoms connected with menopause and the diseases associated with menopause, as well as how menopausal symptoms are managed.
Point of view: laws of urodynamics.

R. Ryall,V. Marshall

DOI: https://doi.org/10.1016/0090-4295(82)90555-6

IF: 2.633

1982-07-01

Urology

Abstract:
Study on gut microbiota and metabolomics in postmenopausal women

Xinyuan Xie,Jinbin Song,Yue Wu,Mei Li,Wenfeng Guo,Shuang Li,Yanwu Li

DOI: https://doi.org/10.1186/s12905-024-03448-7

2024-11-23

BMC Women s Health

Abstract:Menopausal syndrome, occurring during the menopausal stage in women, manifests as symptoms stemming from decreased estrogen levels, such as hot flashes, insomnia, mental disorders (anxiety, depression), and osteoporosis. The bulk of studies have indicated alterations in the gut microbiota of those experiencing menopause syndrome compared to healthy women. However, This article focuses on the alterations in gut microbiota in perimenopausal women. Our study utilized 16 s rRNA sequencing to determine the differences in the gut microbiota and metabolites among 44 menopausal syndrome women. The distribution of gut microbiota in postmenopausal women varies based on the level of follicle stimulating hormone, with changes in gut microbiota abundance taking precedence over symptom onset. Fecal metabolites reveal changes in several metabolites, including Amino acid metabolism (Tyrosine, Tryptophan), Lipid metabolism (Alpha linolenic acid metabolism), and other metabolites. Disturbances in lipid metabolism, triggered by hormonal level fluctuations, can contribute to the development of osteoporosis.

public, environmental & occupational health,obstetrics & gynecology
Obesity and sexual health: focus on postmenopausal women

F. Barbagallo,L. Cucinella,L. Tiranini,P. Chedraui,A. E. Calogero,R. E. Nappi

DOI: https://doi.org/10.1080/13697137.2024.2302429

2024-01-24

Climacteric

Abstract:Menopause is a cardiometabolic transition with many women experiencing weight gain and redistribution of body fat. Hormonal changes may affect also several dimensions of well-being, including sexual function, with a high rate of female sexual dysfunction (FSD), which displays a multifactorial etiology. The most important biological factors range from chronic low-grade inflammation, associated with hypertrophic adipocytes that may translate into endothelial dysfunction and compromised blood flow through the genitourinary system, to insulin resistance and other neuroendocrine mechanisms targeting the sexual response. Psychosocial factors include poor body image, mood disorders, low self-esteem and life satisfaction, as well as partner's health and quality of relationship, and social stigma. Even unhealthy lifestyle, chronic conditions and putative weight-promoting medications may play a role. The aim of the present narrative review is to update and summarize the state of the art on the link between obesity and FSD in postmenopausal women, pointing to the paucity of high-quality studies and the need for further research with validated end points to assess both biomarkers of obesity and FSD. In addition, we provide general information on the diagnosis and treatment of FSD at menopause with a focus on dietary interventions, physical activity, anti-obesity drugs and bariatric surgery.

obstetrics & gynecology

Energy metabolism in neuronal/glial induction and in iPSC models of brain disorders.

Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women

Plant Heat Adaptation: priming in response to heat stress

Obesity and menopause

Cardiovascular Changes in Menopause

Optical system invariant to second-order aberrations.

Detrimental Changes in Health during Menopause: The Role of Physical Activity

[Quaking mice: study of sleep and of epileptic seizures].

Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women

Plasma Metabolic Profiles In Women Are Menopause Dependent

The Importance of Nutrition in Menopause and Perimenopause-A Review

Effects of High Fat Diet on Metabolic Health Vary by Age of Menopause Onset

Sacrococcygeal appendage with femur: exoparasitic pyropagus twin, mature teratoma, or disorganization-like syndrome?

Heart Failure in Menopause: Treatment and New Approaches

The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis

Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women

Endocrinology of Menopause

Point of view: laws of urodynamics.

Study on gut microbiota and metabolomics in postmenopausal women

Obesity and sexual health: focus on postmenopausal women